Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:07 pm Sale |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 4,437,968 7.800% |
-271,530 (-5.77%) |
Filing History |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Redmile Group LLC | 2,711,616 6.900% |
2,711,616 (New Position) |
Filing History |
| 2021-02-16 4:07 pm Purchase |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Redmile Group LLC | 1,378,319 5.700% |
1,378,319 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Beam Therapeutics Inc. BEAM |
Redmile Group LLC | 3,778,262 6.500% |
3,778,262 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 667,816 5.200% |
667,816 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | AVITA Medical, Inc. RCEL |
Redmile Group LLC | 1,707,386 7.900% |
1,707,386 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Atreca, Inc. BCEL |
Redmile Group LLC | 2,476,068 8.260% |
1,339,262 (+117.81%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 63,436 5.990% |
-50,000 (-44.08%) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 3,448,030 9.040% |
3,448,030 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 22,125,489 8.500% |
-3,357,280 (-13.17%) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Allakos Inc. ALLK |
Redmile Group LLC | 2,667,451 5.080% |
-366,075 (-12.07%) |
Filing History |
| 2021-02-16 4:05 pm Purchase |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Redmile Group LLC | 2,322,557 6.690% |
2,322,557 (New Position) |
Filing History |
| 2021-02-16 4:05 pm Purchase |
2020-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 6,758,794 8.810% |
6,758,794 (New Position) |
Filing History |
| 2021-01-12 4:18 pm Purchase |
2021-01-08 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 12,993,888 14.100% |
332,152 (+2.62%) |
Filing History |
| 2020-12-15 4:14 pm Purchase |
2020-12-11 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,438,032 13.500% |
8,216 (+0.24%) |
Filing History |
| 2020-11-27 4:02 pm Purchase |
2020-11-17 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 240,593 37.600% |
240,593 (New Position) |
Filing History |
| 2020-10-15 5:23 pm Purchase |
2020-10-14 | 13D | Shattuck Labs, Inc. STTK |
Redmile Group LLC | 5,619,914 13.500% |
5,619,914 (New Position) |
Filing History |
| 2020-10-15 4:08 pm Purchase |
2020-10-05 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 14,246,125 51.600% |
14,246,125 (New Position) |
Filing History |
| 2020-09-09 8:29 pm Purchase |
2020-09-09 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,429,816 14.200% |
285,816 (+9.09%) |
Filing History |
| 2020-06-17 8:26 pm Purchase |
2020-06-11 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 12,661,736 14.900% |
1,434,928 (+12.78%) |
Filing History |